肥大细胞在变应性鼻炎发病机制中的应用研究

彭海森; 朱新华

doi:10.13201/j.issn.1001-1781.2018.02.019

肥大细胞在变应性鼻炎发病机制中的应用研究

彭海森,
朱新华^,

- 南昌大学第二附属医院耳鼻咽喉头颈外科(南昌, 330006)
基金项目:
国家自然科学基金项目（No：81560171）；江西省优势科技创新团队专项计划（No：S2016RCTDB0016）

详细信息

通讯作者: 朱新华,E-mail:zhuxinhua2003@126.com

中图分类号: R765.21

收稿日期: 2017-11-02

Study on the application of mast cells in the pathogenesis of allergic rhinitis

PENG Haisen,
ZHU Xinhua^,

More Information

Corresponding author: ZHU Xinhua, E-mail: zhuxinhua2003@126.com

Received Date: 02 November 2017

摘要

- 鼻炎,变应性 /
- 肥大细胞 /
- 发病机制 /
- 治疗
Abstract: The pathogenesis of allergic rhinitis (AR) is extremely complex. In recent years, a variety of allergens and other complexes have been developed to induce a series of signal transduction mechanisms by activating mast cells. Intracellular media release (mast cells, MCs) play an important role in the pathogenesis of AR. In this paper, we reviewed the progress of mast cells in the pathogenesis of allergic rhinitis in recent years in order to further understand its role in the pathogenesis of allergic rhinitis and provide new ideas on the therapeutic target for allergic rhinitis.
- rhinitis, allergic /
- mast cell /
- pathogenesis /
- treatment

HTML全文

参考文献(28)

[1]	VARSHNEY J, VARSHNEY H.Allergic Rhinitis:an Overview[J].Indian J Otolaryngol Head Neck Surg, 2015, 67:143-149.
[2]	ZHANG Y, ZHANG L.Prevalence of allergic rhinitis in China[J].Allergy Asthma Immunol Res, 2014, 6:105-113.
[3]	程雷.变应性鼻结膜炎变应原免疫治疗指南(草案)要点解读[J].临床耳鼻咽喉头颈外科杂志, 2017, 31(17):1304-1306.
[4]	CHO K A, PARK M, KIM Y H, et al.Th17 cellmediated immune responses promote mast cell proliferation by triggering stem cell factor in keratinocytes[J].Biochem Biophys Res Commun, 2017, 487:856-861.
[5]	MODENA B D, DAZY K, WHITE A A.Emerging concepts:mast cell involvement in allergic diseases[J].Transl Res, 2016, 174:98-121.
[6]	LU Y, CAI S, NIE J, et al.The natural compound nujiangexanthone A suppresses mast cell activation and allergic asthma[J].Biochem Pharmacol, 2016, 100:61-72.
[7]	RIBATTI D.The development of human mast cells.An historical reappraisal[J].Exp Cell Res, 2016, 342:210-215.
[8]	AROCK M.Mast cell differentiation:still open questions[J]?Blood, 2016, 127:373-374.
[9]	SCHMETZER O, VALENTIN P, CHURCH M K, et al.Murine and human mast cell progenitors[J].Eur J Pharmacol, 2016, 778:2-10.
[10]	SCHMIT D, LE D D, HECK S, et al.Allergic airway inflammation induces migration of mast cell populations into the mouse airway[J].Cell Tissue Res, 2017.
[11]	LIN K C, HUANG D Y, HUANG D W, et al.Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response[J].J Mol Med (Berl), 2016, 94:183-194.
[12]	LEE S H, SHIN H J, KIM D Y, et al.Streptochlorin suppresses allergic dermatitis and mast cell activation via regulation of Lyn/Fyn and Syk signaling pathways in cellular and mouse models[J].PLoSOne, 2013, 8:e74194.
[13]	KIM J H, KIM A R, KIM H S, et al.Rhamnus davurica leaf extract inhibits Fyn activation by antigen in mast cells for anti-allergic activity[J].BMC Complement Altern Med, 2015, 15:80.
[14]	WU W, WANG T, DONG J J, et al.Silencing of ckit with small interference RNA attenuates inflammation in a murine model of allergic asthma[J].Int JMol Med, 2012, 30:63-68.
[15]	WU W, CHEN H, LI Y M, et al.Intranasal sirna targeting c-kit reduces airway inflammation in experimental allergic asthma[J].Int J Clin Exp Pathol, 2014, 7:5505-5514.
[16]	LAUMONNIER Y, SCHMUDDE I, KHL J.The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma[J].Curr Allergy Asthma Rep, 2011, 11:122-130.
[17]	SCHAFER B, PILIPONSKY A M, OKA T, et al.Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice[J].JAllergy Clin Immunol, 2013, 131:541-8.e1-9.
[18]	LI H, XU E, HE M.Cytokine Responses to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients[J].Inflammation, 2015, 38:2216-2223.
[19]	ZHANG Y Y, YU Y Y, ZHANG Y R, et al.The modulatory effect of TLR2 on LL-37-induced human mast cells activation[J].Biochem Biophys Res Commun, 2016, 470:368-374.
[20]	刘月辉, 陶泽璋.Toll样受体与特异性免疫系统及变应性鼻炎的相关研究[J].临床耳鼻咽喉头颈外科杂志, 2012, 26(2):92-96.
[21]	CUI X Y, CHEN X, YU C J, et al.Increased expression of toll-like receptors 2and 4and related cytokines in persistent allergic rhinitis[J].Otolaryngol Head Neck Surg, 2015, 152:233-238.
[22]	MIYAZAKI D, NAKAMURA T, OHBAYASHI M, et al.Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade[J].Int Immunol, 2009, 21:187-201.
[23]	HARVIMA I T, LEVI-SCHAFFER F, DRABER P, et al.Molecular targets on mast cells and basophils for novel therapies[J].J Allergy Clin Immunol, 2014, 134:530-44.
[24]	IM Y S, LEE B, KIM E Y, et al.Antiallergic effect of gami-hyunggyeyeongyotang on ovalbumin-induced allergic rhinitis in mouse and human mast cells[J].JChin Med Assoc, 2016, 79:185-194.
[25]	ZHANG N, LI H, JIA J, et al.Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse[J].Cell Immunol, 2015, 298:88-95.
[26]	SHAO Y Y, ZHOU Y M, HU M, et al.The anti-allergic rhinitis effect of traditional Chinese medicine of Shenqi by regulating mast cell degranulation and Th1/Th2 cytokine balance[J].Molecules, 2017, 22.
[27]	BLUNT M D, WARD S G.Ward, Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system:success, disappointment, and new opportunities[J].Front Immunol, 2012, 3:226.
[28]	DRABER P, HALOVA I, POLAKOVICOVA I, et al.Signal transduction and chemotaxis in mast cells[J].Eur J Pharmacol, 2016, 778:11-23.